Curebase is a provider of decentralized clinical research software solutions and services to patients and medical providers.
Sign up today and learn more about Curebase Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Curebase Stock
Curebase builds a digital clinical trial assistant that would alter how medical providers discover, activate, and administer clinical trials for their patients. It aims to run clinical trials faster and cheaper than anyone else via software that reduces recruitment times, automates manual steps, and lets drug companies distribute their trials to clinics. The company was established in 2017 and is based in San Francisco, California.
Bold Capital Partners
Liquid 2 Ventures
Whatnot, Cerebral, Newfront Insurance, Swiftly, Mux, Parsley Health, Curebase
Founder & CEO
Vice President Of Business Development
Chief Operating Officer
TechCrunch - Aug, 22 2018All 59 startups that launched today at Y Combinator’s S18 Demo Day 2
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase